{{Rsnum
|rsid=12518194
|Chromosome=5
|position=25951452
|Orientation=plus
|GMAF=0.2369
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 38.1 | 49.6 | 12.4
| HCB | 73.0 | 23.4 | 3.6
| JPT | 73.5 | 25.7 | 0.9
| YRI | 100.0 | 0.0 | 0.0
| ASW | 89.5 | 10.5 | 0.0
| CHB | 73.0 | 23.4 | 3.6
| CHD | 73.4 | 25.7 | 0.9
| GIH | 36.6 | 46.5 | 16.8
| LWK | 99.1 | 0.9 | 0.0
| MEX | 56.9 | 32.8 | 10.3
| MKK | 71.8 | 25.6 | 2.6
| TSI | 33.3 | 51.0 | 15.7
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs12518194
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19404256
|Annotation=This SNP on 5p14.1 was associated with autism spectrum disorder in a combined analysis of four GWAS data sets with a total of more than 10,000 subjects of European ancestry. This SNP is in an intergenic region between CDH10 and CDH9 that contains several highly conserved genomic elements.
|Drugs=
|Drug Classes=
|Diseases=Autism Spectrum Disorder
|Curation Level=Curated
|PharmGKB Accession ID=PA164741097
}}

{{PMID Auto
|PMID=19456320
|Title=A genome-wide association study of autism reveals a common novel risk locus at 5p14.1.
|OA=1
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs12518194
|overall_frequency_n=29
|overall_frequency_d=128
|overall_frequency=0.226562
|n_genomes=17
|n_genomes_annotated=0
|n_haplomes=20
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}